
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for iShares Nasdaq US Biotechnology UCITS ETF.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer2B70.DE Technical Analysis Summary
iShares Nasdaq US Biotechnology UCITS ETF stock currently trades in a neutral range, with no clear dominance from buyers or sellers.
Technical conditions suggest iShares Nasdaq US Biotechnology UCITS ETF is consolidating, awaiting a decisive move.
RSI (14): 69.31
Stochastic %K: 91.22
Williams %R: -4.48
Rate of Change (ROC): 9.67
Takeaway:iShares Nasdaq US Biotechnology UCITS ETF shows strong bullish momentum, with buyers firmly in control.
MACD: 0.11
ADX: 15.83
ATR (14): 0.14
CCI (14): 186.62
Takeaway:iShares Nasdaq US Biotechnology UCITS ETF shows a neutral trend, with weak conviction and limited volatility.
Takeaway:iShares Nasdaq US Biotechnology UCITS ETF trades near the upper band, signaling overbought conditions and risk of pullback.
Takeaway:iShares Nasdaq US Biotechnology UCITS ETF trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:2B70.DE shows overheated money flow, with risk of pullback from overbought conditions.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
MFI above 80 → overbought conditions may limit upside.
Overall Recommendation:Technical indicators for iShares Nasdaq US Biotechnology UCITS ETF are mixed, suggesting a Hold or wait-and-see approach.